Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer
- 1 September 2002
- journal article
- Published by Elsevier BV in Urology
- Vol. 60 (3), 7-11
- https://doi.org/10.1016/s0090-4295(02)01560-1
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapyUrology, 2000
- 4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate CancerEuropean Urology, 2000
- NEOADJUVANT HORMONAL THERAPY BEFORE RADICAL PROSTATECTOMY AND RISK OF PROSTATE SPECIFIC ANTIGEN FAILUREJournal of Urology, 1999
- HORMONAL TREATMENT BEFORE RADICAL PROSTATECTOMY: A 3-YEAR FOLLOWUPJournal of Urology, 1998
- WHY NEOADJUVANT ANDROGEN DEPRIVATION PRIOR TO RADICAL PROSTATECTOMY IS UNNECESSARYUrologic Clinics of North America, 1996
- Randomized Study of Neoadjuvant Testicular Androgen Ablation Therapy Before Radical Prostatectomy in Men with Clinically Localized Prostate CancerJournal of Urology, 1996
- Effect of Neoadjuvant Endocrine Therapy (Combined Androgen Blockade) on Normal Prostate and Prostatic CarcinomaThe American Journal of Surgical Pathology, 1996
- Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate CancerJournal of Urology, 1995
- High failure rate associated with long‐term follow‐up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancerBJU International, 1995
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941